Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 U.S. states

Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study

(2022) Michael A Irvine et al.   Lancet Public Health

Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden

(2021) Neda J. Kazerouni et al.   DRUG AND ALCOHOL DEPENDENCE

Pharmacist furnishing of naloxone in California: A follow-up analysis

(2021) Talia Puzantian et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Naloxone Availability in Retail Pharmacies and Neighborhood Inequities in Access

(2020) Kathleen L. Egan et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007–2017

(2020) Ryan K. McBain et al.   ANNALS OF INTERNAL MEDICINE

Naloxone availability and dispensing in Indiana pharmacies 2 years after the implementation of a statewide standing order

(2020) Lori Ann Eldridge et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Indiana community pharmacist preceptors’ knowledge and perceptions of medication-assisted treatment

(2020) Elizabeth S. Davenport et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints

(2020) Alex K. Gertner et al.   HEALTH SERVICES RESEARCH

Opioid Policy Changes During the COVID-19 Pandemic - and Beyond

(2020) Corey S. Davis et al.   Journal of Addiction Medicine

Socio-ecological and pharmacy-level factors associated with naloxone stocking at standing-order naloxone pharmacies in New York City

(2020) Bilal Abbas et al.   DRUG AND ALCOHOL DEPENDENCE

When Prescribing Isn’t Enough — Pharmacy-Level Barriers to Buprenorphine Access

(2020) Hannah L.F. Cooper et al.   NEW ENGLAND JOURNAL OF MEDICINE

Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA

(2020) Lucas G. Hill et al.   ADDICTION

Pharmacists are missing an opportunity to save lives and advance the profession by embracing opioid harm reduction

(2019) Lucas G. Hill et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Impact of student pharmacist–led naloxone academic detailing at community pharmacies in Texas

(2019) Kirk E. Evoy et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Access to naloxone at community pharmacies under the Massachusetts statewide standing order

(2019) Cindy Wu et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Assessment of naloxone availability in Georgia community pharmacies

(2019) Rebecca H. Stone et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016

(2018) B.E. Meyerson et al.   DRUG AND ALCOHOL DEPENDENCE

Characteristics and Prescribing Practices of Clinicians Recently Waivered to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder

(2018) Christopher M. Jones et al.   ADDICTION

Naloxone Accessibility Without a Prescriber Encounter Under Standing Orders at Community Pharmacy Chains in Texas

(2018) Kirk E. Evoy et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Provision of Naloxone Without a Prescription by California Pharmacists 2 Years After Legislation Implementation

(2018) Talia Puzantian et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Naloxone Availability and Pharmacy Staff Knowledge of Standing Order for Naloxone in Pennsylvania Pharmacies

(2018) Rachel L. Graves et al.   Journal of Addiction Medicine

Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia

(2017) J. Douglas Thornton et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Impact of Medicaid Expansion on Medicaid-covered Utilization of Buprenorphine for Opioid Use Disorder Treatment

(2017) Hefei Wen et al.   MEDICAL CARE

Prescribe to Prevent

(2016) Jamie K. Lim et al.   Journal of Addiction Medicine

Effect of Medicaid Expansions on Health Insurance Coverage and Access to Care among Low-Income Adults with Behavioral Health Conditions

(2015) Hefei Wen et al.   HEALTH SERVICES RESEARCH